First Wave BioPharma Logo
US33749P5070
A41ENZ

First Wave BioPharma

Loading quotes...

Forecast

Buy
  1
Hold
  0
Sell
  0

There is currently no news available for this company. We are working on adding more providers to change this.

Financials

In the last quarter, First Wave BioPharma had revenue of €75.25k and net profit of -€11.23m
(EUR) June 2026
YoY
Revenue 75.25k -
Gross profit -535.56k -
Net profit -11.23m 1,226.19%
EBITDA -2.16m 300.26%

Fundamentals

Metric Value
Market capitalization
€8.84m
Number of shares
3.36m
52-week high/low
€6.04 - €1.63
Dividends No
Beta
1.88
P/E ratio
-0.70
PEG ratio
0.01
P/B ratio
1.06
P/S ratio
63.32

Company profile

Name
First Wave BioPharma
CEO
Jason David Sawyer
Employees 2
🍪

Parqet  uses cookies. Learn more